Form 4 holding
General Manager
NeuroSense Therapeutics Ltd.
- Security class
- Ordinary Shares
- Shares / value
- 521,806
- Estimated value
- $401,268
- Report date
- 26 Mar 2026
- Price
- $0.7690
- Ownership
- Direct
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|